ArticleMolecular cancer therapeutics2019

LCL161, a SMAC-mimetic, Preferentially Radiosensitizes Human Papillomavirus-negative Head and Neck Squamous Cell Carcinoma.

Linlin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.